Reaction #67135

ord-e120ac370a5042a6b1b5bb261b7a7f83

Reaction equation

COc1ncc(B2OC(C)(C)C(C)(C)O2)cc1N
2-(methyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine
O.O=P([O-])([O-])[O-].[K+].[K+].[K+]
tripotassium phosphate monohydrate
COc1ncc(B2OC(C)(C)C(C)(C)O2)cc1N
2-(methoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine
Cc1ccc(S(=O)(=O)n2ncc3c(-c4nnc(CN5C[C@@H](C)O[C@@H](C)C5)o4)cc(Br)cc32)cc1
6-Bromo-4-(5-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl}-1,3,4-oxadiazol-2-yl)-1-[(4-methylphenyl)sulfonyl]-1H-indazole
COc1ncc(-c2cc(-c3nnc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cnn(S(=O)(=O)c4ccc(C)cc4)c3c2)cc1N
title compound
Yield 43.6%
COc1ncc(-c2cc(-c3nnc(CN4C[C@@H](C)O[C@@H](C)C4)o3)c3cnn(S(=O)(=O)c4ccc(C)cc4)c3c2)cc1N
5-{4-(5-{[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl}-1,3,4-oxadiazol-2-yl)-1-[(4-methyl phenyl)sulfonyl]-1H-indazol-6-yl}-2-(methyloxy)-3-pyridinamine
Yield 43.6%

Conditions

Temperature
80°CELSIUS
Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Temperaturethe reaction mixture heated at 80° C. for a further 18 h
  2. 2
    OtherThe solvent was removed in vacuo
  3. 3
    Otherthe residue partitioned between DCM (50 ml) and water (50 ml)
  4. 4
    OtherThe layers were separated (hydrophobic frit)
  5. 5
    Concentrationthe organic concentrated in vacuo
  6. 6
    Otherthe residue purified by column chromatography, loading in dichloromethane
  7. 7
    Otherpurified on a silica cartridge (100 g)
  8. 8
    Otherover 40 mins
  9. 9
    Concentrationconcentrated in vacuo to a brown gum
  10. 10
    OtherThis was purified again by column chromatography, loading in dichloromethane
  11. 11
    Otherpurified on a silica cartridge (50 g)
  12. 12
    Otherover 40 mins
  13. 13
    Otherevaporated in vacuo

Procedure

6-Bromo-4-(5-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl}-1,3,4-oxadiazol-2-yl)-1-[(4-methylphenyl)sulfonyl]-1H-indazole (680 mg, 1.244 mmol) was dissolved in 1,4-dioxane (15 ml) and water (1.5 ml). 2-(methyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine (311 mg, 1.244 mmol), bis(diphenylphosphino)ferrocene palladium dichloride (182 mg, 0.249 mmol) and tripotassium phosphate monohydrate (860 mg, 3.73 mmol) were added and the reaction mixture heated at 80° C. for 2 h. 2-(methoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinamine (0.1 eq, 31 mg) was added and the reaction mixture heated at 80° C. for a further 18 h. The solvent was removed in vacuo and the residue partitioned between DCM (50 ml) and water (50 ml). The layers were separated (hydrophobic frit), the organic concentrated in vacuo and the residue purified by column chromatography, loading in dichloromethane and purified on a silica cartridge (100 g), using a 0-30% methanol(+1% triethylamine)-dichloromethane over 40 mins. The appropriate fractions were combined and concentrated in vacuo to a brown gum. This was purified again by column chromatography, loading in dichloromethane and purified on a silica cartridge (50 g) using a 0-100% ethyl acetate-cyclohexane+0-20% methanol over 40 mins. The appropriate fractions were combined and evaporated in vacuo to give the title compound as a yellow solid (320 mg).

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08524751B2uspto-grants-2013_09